XSTO
PTRK
Market cap13mUSD
Jun 18, Last price
7.82SEK
1D
2.36%
1Q
-12.13%
IPO
-83.54%
Name
Physitrack PLC
Chart & Performance
P/E
—
P/S
0.72
EPS
—
Div Yield, %
—
Shrs. gr., 5y
7.68%
Rev. gr., 5y
68.21%
Revenues
16m
+6.61%
Net income
-6m
L
CFO
3m
+18.08%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Physitrack PLC operates globally as a digital healthcare innovator. The company delivers a proprietary cloud-based Software-as-a-Service (SaaS) platform, utilized by a diverse range of healthcare providers, from individual practitioners to large organizations, to completely digitalize the patient journey—from their initial contact through ongoing interactions and tracking of progress. Additionally, Physitrack offers virtual care solutions that address three key areas for patients and insurance plan members: preventive and wellness support, care for acute and chronic conditions, and surgical recovery. These virtual care services are supplied to healthcare enterprises such as private and public hospitals, clinics, and other health businesses. Founded in 2012, the company was formerly known as Physitrack Limited before rebranding to Physitrack PLC in May 2021 and is based in London, United Kingdom.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑11 | 2019‑11 | 2018‑11 | 2017‑11 | 2016‑11 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||